Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01209923 · ClinicalTrials.gov registry record · NA

Validation of the Stayhealthy BC1 Body Comp Analyzer

A NA study of Body Composition, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
362
Enrollment target
1
Study location

NCT01209923 is a NA study of Body Composition that has completed, run by University of Southern California. The registered enrollment target is 362 participants, above the 98-participant average among 20 other Body Composition trials with a reported enrollment target (269% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01209923, a NA study of Body Composition, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
362 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults. The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children. We hypothesized that the BC1 would provide similar measures of body fat between devices with acceptable limits of agreement.

Conditions Studied

Interventions

  • DEVICE BC1

Study Locations (1)

California

  • USC Clinical Exercise Research Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 362 participants
Start Date 2007-05
Est. Completion 2009-08
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT01209923

The ClinicalTrials.gov registry entry for NCT01209923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 362 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 20 other Body Composition trials with a reported enrollment target (269% higher). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Body Composition appearing as the primary indexed condition, and to 1 intervention - of which BC1 is the first listed.

NCT01209923 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01209923 about?

NCT01209923 is a clinical study titled "Validation of the Stayhealthy BC1 Body Comp Analyzer". The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults. The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children...

What is the current status of trial NCT01209923?

This trial is currently completed. It is a NA study. The enrollment target is 362 participants. The study started on 2007-05. Estimated completion is 2009-08.

What conditions does trial NCT01209923 study?

This clinical trial studies the following conditions: Body Composition.

What interventions are being tested in trial NCT01209923?

The interventions under investigation include: BC1 (DEVICE).

Who is sponsoring clinical trial NCT01209923?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01209923 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Composition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.